Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

11 Biotechnology Stocks to Sell Now

By Portfolio Grader
This week, the ratings of 11 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

6 Semiconductor Stocks to Sell Now

By Portfolio Grader
This week, the overall grades of six semiconductor stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Insurance Stocks to Sell Now

By Portfolio Grader
The ratings of four insurance stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Service Stocks to Sell Now

By Portfolio Grader
This week, the overall grades of four service stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Medical Technology Stocks to Sell Now

By Portfolio Grader
For the current week, the overall ratings of three medical technology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Crummy Earnings Momentum — FNBN GYRO APU SGY HXM

By Portfolio Grader
This week, these five stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

All-Day Breakfast Won’t Help MCD Stock

By James Brumley, InvestorPlace Feature Writer
McDonald's Corporation (MCD) is working hard, but it's not working smart. Case in point? Round-the-clock breakfast.

5 Worst Sectors to Avoid This Week

By Portfolio Grader
According to the Portfolio Grader database this week, the energy services, marine, construction and engineering, electrical equipment and medical technology sectors are at the bottom.

5 Stocks With Awful Cash Flow — HXM TWGP HELI STP ATPG

By Portfolio Grader
This week, these five stocks have the worst ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Bad Earnings Growth — MMLP TCI CGG BGC SHOS

By Portfolio Grader
This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

Monsanto (MON) Earnings Preview: Will Soy Save the Day on Wednesday?

By James Brumley, InvestorPlace Feature Writer
As bad as things have been for MON stock of late, the Monsanto earnings news due Wednesday could make them even worse.

5 Stocks With Poor Operating Margin Growth — CTEL WIFI KEG TWGP HXM

By Portfolio Grader
This week, these five stocks have the worst ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader.

12 Metals and Mining Stocks to Sell Now

By Portfolio Grader
The ratings of 12 metals and mining stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Tech Services Stocks to Sell Now

By Portfolio Grader
For the current week, the overall ratings of three tech services stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

6 Capital Markets Stocks to Sell Now

By Portfolio Grader
For the current week, the overall ratings of six capital markets stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Media Stocks to Sell Now

By Portfolio Grader
For the current week, the overall ratings of three media stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Biogen (BIIB): Why Aducanumab Excitement Might Be Overblown

By Craig Adeyanju, InvestorPlace Contributor
Biogen Inc (BIIB) recently shot up after reporting positive results from aducanumab's phase 1b study. However, there are some important takeaways from the report that many seem to be missing.

GME: Slow Bleed in GameStop Stock Resumes

By Matt Thalman, InvestorPlace Contributor
GameStop earnings just missed expectations, and GME dropped a bit as of a result. We learned nothing that really condems GameStop stock ... but what's to love, either?

The BlackBerry Earnings Report Still Doesn’t Make BBRY Stock a Buy

By James Brumley, InvestorPlace Feature Writer
BlackBerry has successfully shrunk its way to success. Unfortunately, the price of BBRY stock hasn't adjusted to the new company size yet.
Load More Articles